Literature DB >> 24009965

Urine methylmalonic acid levels in HIV-infected adults with peripheral neuropathy.

Adediran Adewumi1, Adeyemo Titilope, Akinbami Akinsegun, Osunkalu Vincent, Akanmu Alani.   

Abstract

BACKGROUND: Cobalamin deficiency and peripheral neuropathy (PN) are commonly seen in HIV-infected adults. The level of urine methylmalonic acid (UMMA), a reliable indicator of tissue cobalamin status, was determined in HIV infected subjects with and without PN to establish this association.
METHODS: One hundred and ninety-eight (198) consenting HIV infected subjects with and without PN were recruited for the study. UMMA level was determined by Cation Exchange High Performance Liquid Chromatography (HPLC) with Ultraviolet detector in 165 subjects. Simple proportions of patients with raised UMMA (defined as value> 3.4 mg in 24hr) were determined for each arm.
RESULTS: Among the 198 subjects studied, 146 had PN and 52 had no PN. From the 165 subjects whose UMMA was studied, raised UMMA was found in 76.6% (36 of 47) of subjects with no PN as compared with 53.4% (63 of 118) of those with PN (p=0.018).
CONCLUSION: Cobalamin deficiency (measured by UMMA level) even though common in HIV infected subjects, may not be the cause of peripheral neuropathy in these subjects.

Entities:  

Keywords:  Cobalamin deficiency; HIV infection; Peripheral Neuropathy; Urine methylmalonic acid (UMMA)

Year:  2013        PMID: 24009965      PMCID: PMC3755835     

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


  17 in total

1.  Urinary methylmalonic acid test may have greater value than the total homocysteine assay for screening elderly individuals for cobalamin deficiency.

Authors:  Eric J Norman
Journal:  Clin Chem       Date:  2004-08       Impact factor: 8.327

Review 2.  Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment.

Authors:  Lawrence R Solomon
Journal:  Blood Rev       Date:  2006-07-11       Impact factor: 8.250

3.  Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases.

Authors:  K D Miller; M Cameron; L V Wood; M C Dalakas; J A Kovacs
Journal:  Ann Intern Med       Date:  2000-08-01       Impact factor: 25.391

Review 4.  Neurological complications of HIV infection.

Authors:  Justin C McArthur; Bruce J Brew; Avi Nath
Journal:  Lancet Neurol       Date:  2005-09       Impact factor: 44.182

5.  Effect of dietary intake and protease inhibitors on serum vitamin B12 levels in a cohort of human immunodeficiency virus-positive patients.

Authors:  Margo N Woods; Alice M Tang; Janet Forrester; Clara Jones; Kristy Hendricks; Bei Ding; Tamsin A Knox
Journal:  Clin Infect Dis       Date:  2003       Impact factor: 9.079

6.  Serum vitamin B12 and transcobalamin levels in early HIV disease.

Authors:  S A Rule; M Hooker; C Costello; W Luck; A V Hoffbrand
Journal:  Am J Hematol       Date:  1994-11       Impact factor: 10.047

7.  Urine methylmalonic acid measurements for the assessment of cobalamin deficiency related to neuropsychiatric disorders.

Authors:  M Gültepe; O Ozcan; K Avşar; M Cetin; A S Ozdemir; M Gök
Journal:  Clin Biochem       Date:  2003-06       Impact factor: 3.281

Review 8.  Diagnosis and management of HIV-associated neuropathy.

Authors:  Alejandra Gonzalez-Duarte; Jessica Robinson-Papp; David M Simpson
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

9.  Multiple micronutrient supplementation improves vitamin B₁₂ and folate concentrations of HIV infected children in Uganda: a randomized controlled trial.

Authors:  Grace Ndeezi; James K Tumwine; Christopher M Ndugwa; Bjørn J Bolann; Thorkild Tylleskär
Journal:  Nutr J       Date:  2011-05-21       Impact factor: 3.271

10.  Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.

Authors:  Andrew Boulle; Catherine Orrel; Richard Kaplan; Gilles Van Cutsem; Matthew McNally; Katherine Hilderbrand; London Myer; Matthias Egger; David Coetzee; Gary Maartens; Robin Wood
Journal:  Antivir Ther       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.